Perrigo (PRGO) targets organic net sales CAGR of 2.5% to 4.5%
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that at its Virtual Investor Day, scheduled to begin today at
Perrigo's unique complementary businesses enables each individually to play a specific reinforcing role, where 1) store brands and infant formula generate cash for investments into the Company's key higher margin, higher growth or 'High-Grow' brands, 2) branding and innovation capabilities that deliver brand and store brand demand generation leading to stronger customer partnerships, 3) consumer-led innovation that is scaled across brands, store brands and geographies, and 4) the Company's global supply chain scale and reach with 100-plus molecules, at 100% consumer price point coverage, serves the most consumers.
The Company's plan to drive cash flow and total shareholder return is anchored behind its 'Three-S' plan – 'Stabilizing' Consumer Self-Care Americas (CSCA) store brand and infant formula businesses; 'Streamlining' the global portfolio, enterprise operating model and Consumer Self-Care International (CSCI) business; and 'Strengthening' what is working by prioritizing and increasing investments behind key 'High-Grow' brands.
President and CEO
In conjunction with its Investor Day, the Company is providing select financial targets for fiscal year 2025 and for fiscal years 2025 to 2027.
Fiscal Year 2025 Financial Targets1 (fiscal year 2024 actuals as the baseline):
- All-in net sales growth of 1% to 3%.
- Organic net sales growth of 2.5% to 4.5%.
- Adjusted gross margin of approximately 40%.
- Adjusted operating margin of approximately 15%.
- Adjusted diluted earnings per share ("EPS") range of
$2.90 to$3.10 , equating to growth of 13% to 21%. - Operating cash flow conversion to adjusted net income of approximately 100%.
- Free cash flow as a percentage of net sales of approximately 6%.
- Net leverage of approximately 3.5x adjusted EBITDA.
Fiscal Years 2025 to 2027 Financial Targets1, (fiscal year 2024 actuals as the baseline):
- Organic net sales CAGR of 2.5% to 4.5%.
- Adjusted gross margin expansion of +200 to +400 basis points by 2027.
- Adjusted operating margin expansion of +150 to +250 basis points by 2027.
- Adjusted diluted EPS CAGR of high-single to low-double digit percentage.
- Operating cash flow conversion to adjusted net income of approximately 100% or more.
- Free cash flow as a percentage of net sales of approximately +200 basis points by 2027.
- Net leverage of less than 3x adjusted EBITDA in 2027.
1. Assumes exchange rates constant to fiscal year 2024 actual exchange rates (USD/EURO of approximately
Virtual Investor Day Details
Perrigo's 2025 Virtual Investor Day will start today,
About Perrigo
Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com.
